Cargando…
Hindsight: Review of Preclinical Disease Models for the Development of New Treatments for Uveal Melanoma
The molecular, histopathological, genomic and transcriptomic characteristics of uveal melanoma (UM) have identified four molecular subgroups with different clinical outcomes. Despite the improvements in UM classification and biological pathology, current treatments do not reduce the occurrence of me...
Autores principales: | Goldrick, Caoimhe, Palanga, Letizia, Tang, Bobby, Mealy, Grace, Crown, John, Horgan, Noel, Kennedy, Susan, Walsh, Naomi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210544/ https://www.ncbi.nlm.nih.gov/pubmed/34149931 http://dx.doi.org/10.7150/jca.53954 |
Ejemplares similares
-
A Rare Thyroid Metastasis from Uveal Melanoma and Response to Immunotherapy Agents
por: Collins, Dearbhaile Catherine, et al.
Publicado: (2016) -
Presidential Address: 2020 is Hindsight
por: Dietz, Jill R.
Publicado: (2021) -
2020 in 20/20 hindsight
por: Chernoff, Jonathan
Publicado: (2021) -
Clinical Impact of Immune Checkpoint Inhibitor (ICI) Response, DNA Damage Repair (DDR) Gene Mutations and Immune-Cell Infiltration in Metastatic Melanoma Subtypes
por: Andrieu, Charlotte, et al.
Publicado: (2022) -
Hindsight Is 2019—the Year in Clinical Microbiology
por: Pettengill, Matthew A.
Publicado: (2020)